Stockwinners Market Radar for November 17, 2021 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:32 EST ForgeRock announces partial early lock-up release - ForgeRock announced an upcoming partial early lock-up release with respect to ForgeRock's Class A common stock, pursuant to the terms of the lock-up agreements entered into by ForgeRock's equity holders, including current executive officers and directors, with the underwriters of ForgeRock's initial public offering. Pursuant to the terms of the lock-up agreements, up to 15% of the shares subject to each lock-up agreement may be sold if certain share price and other conditions are met. Accordingly, ForgeRock expects that up to 11.7 million shares will become eligible for sale in the public market at the open of trading on Monday, November 22, 2021.

18:54 EST Destination XL reports Q3 SSS up 22.9% vs. Q3 of 2019

18:48 EST Cisco CEO: Supply chain problems to persist in 2022 - In an interview on CNBC's Mad Money, Chuck Robbins said Cisco grew product orders significantly in Q1. He expects Q2 to be stable and sees improvement in 2H22. The current backlog is the largest in the company's history, he noted. While Robbins sees short-term supply chain issues, he expects the company to navigate through them.

17:46 EST Avis Budget chairman sells 100K shares of common stock - In a regulatory filing, Avis Budget disclosed that its executive chairman Bernardo Hees sold 100K shares of common stock on November 15th in a total transaction size of $27.2M, reducing his stake by about 18%.

17:39 EST Altra Industrial announces refinancing, sees interest expense down $4M-$5M - Altra Industrial Motion announced that the Company has entered into a new five-year credit agreement among the Company and the lenders party to the credit agreement from time to time, which consists of a new $400M term loan and a new $1 billion revolving credit facility. The Company will use the proceeds to repay in full all amounts outstanding on its existing term loan and revolving credit facilities, which have been terminated, and for general corporate purposes, including acquisitions. "We are very pleased with the results of this refinancing," said Carl Christenson, Altra's Chairman and Chief Executive Officer. "Based on the current interest rate environment, we expect this transaction will have the potential to provide us with a reduction in our annual interest expense of approximately $4-$5M. Moreover, this transaction furthers our efforts to strengthen our balance sheet and provides us with the flexibility and capacity to pursue our long-term organic and acquisition growth strategies."

17:23 EST BAE Systems, Boeing and others awarded on $2.4B Air Force modification - BAE Systems (BAESY); Boeing (BA); Booz Allen Hamilton (BAH); Cubic Defense (CUB); L3 Technologies (LHX); Lockheed Martin (LMT); Northrup Grumman (NOC); Raytheon (RTX) were awarded a combined $2.4B modification to the existing multiple award, indefinite-delivery/indefinite-quantity contracts listed above, comprised of firm-fixed-price, fixed-price-incentive-firm, cost-plus-fixed-fee, cost-plus-incentive-firm, and cost reimbursable contract line items. The modification provides for the establishment of production and sustainment contract line items to allow the Department of the Air Force to streamline prototype development, production and sustainment into a single effort to be competed under fair opportunity procedures. Work is expected to be completed by January 9, 2028. All funding will be made available at the delivery order level as contracting actions occur. The Quick Reaction Branch is the contracting activity.

17:18 EST Thryv Holdings to replace Echo Global in S&P 600 at open on 11/24 - The Jordan Company is acquiring Echo Global Logistics in a deal expected to close soon.

17:04 EST ZTO Express lowers FY21 parcel volume growth view to 30.6%-33.5% from 35%-40% - Based on current market and operating conditions, the company revises its previously stated annual guidance. Parcel volume for 2021 is expected to be in the range of 22.2B-22.7B, representing a 30.6%-33.5% increase year over year.

16:51 EST Primerica announces $275M stock buyback - Primerica "announced that its board has authorized a share repurchase program through December 31, 2022, pursuant to which the Company is authorized to repurchase up to $275M of its common stock, with repurchases expected to begin in 2021. This share repurchase program replaces the $300M program that was previously authorized in February 2021 for repurchases through June 30, 2022."

16:34 EST CymaBay announces offering of common stock, pre-funded warrants, no amount given - CymaBay announced that it has commenced an underwritten public offering of its common stock and pre-funded warrants. CymaBay anticipates using the net proceeds from the offering to fund ongoing development of seladelpar and for working capital and general corporate purposes. Piper Sandler and Raymond James are acting as the joint book-running managers for the offering.

16:33 EST Braemar Hotels & Resorts reports October portfolio occupancy of 62.5% - Braemar Hotels & Resorts "reported preliminary portfolio occupancy of 62.5% for the month of October with an average daily rate of approximately $337 resulting in RevPAR of approximately $211. This RevPAR result represents an approximate increase of 12% versus September 2021 and an approximate decrease of 13% versus October 2019. Additionally, for the month of October, Hotel Net Income was $2.3M. Comparable Hotel EBITDA for the month of October was $9.8M, a 108% increase versus September 2021's Comparable Hotel EBITDA of $4.7M."

16:32 EST AEP Ohio rate case settlement approved by PUCO - AEP Ohio, an American Electric Power company, has received approval from the Public Utilities Commission of Ohio for new base rates for electric distribution service. AEP Ohio and 13 others, including the PUCO staff, the Office of the Ohio Consumers' Counsel, large industrial customer groups as well as commercial customers including Kroger Co. and Walmart, and the Ohio Hospital Association had submitted to the PUCO an agreement in March 2021 and was approved by the commissioners today. Under the new rates, residential customers using 1,000 kilowatt-hours per month will see a decrease of $0.71 per month as compared to the rates in the Company's filing. The monthly customer charge will increase to $10 per month from $8.40. Reductions in other rates offset changes to the customer charge. In addition, there will no longer be a reconnection fee for customers disconnected for nonpayment. New base rates will take effect in 14 days. AEP Ohio last updated its base rates in 2011. "Over the last decade, the men and women of AEP Ohio have done a lot of extraordinary work to improve the reliability of the service we provide," said Marc Reitter, AEP Ohio president and chief operating officer. "Working with the Commission staff, the OCC, and many of our largest customers, we have charted a path forward to continue providing safe and electric service. The agreement between the 13 parties recognizes the progress we have made, the work that we still have ahead of us, and holds us accountable for getting the work done."

16:31 EST ViacomCBS says Paramount+ added 1M new subscribers in 'most successful week' - ViacomCBS announced that Paramount+ experienced its most successful week ever, adding more than 1M new subscribers and setting a new record for total signups since its rebrand. The service also set new records for most hours streamed and highest level of subscriber engagement. The successful week was fueled by the premiere of the family-friendly film CLIFFORD THE BIG RED DOG; the new original scripted drama MAYOR OF KINGSTOWN, from YELLOWSTONE co-creator Taylor Sheridan; live NFL ON CBS local market games; the highly anticipated CBS event ADELE ONE NIGHT ONLY; America's most-watched news program, 60 MINUTES; and Paramount+ originals SEAL TEAM, THE GAME and the second season of THE CHALLENGE: ALL STARS, the company said. "This week we ushered in a mix of must-see originals, a blockbuster family film and top-tier sports that appealed to the whole household. This is a content strategy we will continue to lean into as we invest in scaling Paramount+," said Tom Ryan, President and Chief Executive Officer, ViacomCBS Streaming. "The remarkable levels of engagement we are seeing are a testament to the power of great storytelling on the service and the sheer breadth and depth of our content offering."

16:24 EST Biolase issues recommendation to stockholders in favor of reverse stock split - Biolase issued a statement encouraging stockholders to vote in favor of the amendment to the Biolase Certificate of Incorporation to effect a reverse stock split - without reducing the authorized number of shares of common stock -. The special meeting of Biolase stockholders is scheduled to be held on November 19. The reverse stock split will not affect stockholders' percentage ownership of Biolase. The company's Board stated that approving the amendment will: "Help ensure continued listing of our common stock on The Nasdaq Capital Market, Attract institutional investors and promote greater liquidity for our stockholders, Enable us to offer equity compensation to employees and other service providers (and, thus, conserve cash), and Provide that shares of common stock are authorized and available for future uses". The company also stated that Proxy advisory firms ISS and Glass Lewis have recommended that stockholders vote in favor of the reverse stock split.

16:19 EST Sandstorm Gold reports environmental approval of Hod Maden project in Turkey - Sandstorm Gold announced that Lidya Madencilik Sanayi, the operator of the Hod Maden project, has received the final approval of the Environmental Impact Assessment for the project from the Ministry of Environment and Urbanization of Turkey. The results from the Hod Maden Feasibility Study are expected to be released in the coming weeks. This approval triggers several catalysts for Lidya including the application for the final permits and initiating long-lead construction items.

16:16 EST Navitas Semiconductor, Anker sign strategic partnership - Navitas Semiconductor and Anker announced the signing of a new strategic partnership. The new agreement dedicates engineering teams from both Navitas and Anker to be co-located at Anker offices to develop and launch leading-edge GaNFast chargers to accelerate time-to-market. The initial focus will be on next-generation mobile chargers but will expand into the high-growth energy-storage markets. The deal also provides a longer planning horizon for co-operative marketing across all media platforms and in-person events, such as the Consumer Electronics Show, in Las Vegas. The first two fast chargers released under the new partnership are the 30W USB-C and 65W 2C+A chargers in Anker's collaboration with the "League of Legends" multi-player online battle arena video game, played on phones, tablets and laptops. With fast action and intensive, detailed graphics, the game has a high draw on battery power, and fast charging - with portability - is crucial for any LOL gamer.

16:16 EST TechnipFMC to collaborate with Orbital Marine on tidal energy - TechnipFMC "signed a Memorandum of Understanding with Orbital Marine Power to jointly collaborate in tidal energy to accelerate the global commercialization of Orbital's technology and deliver the first commercial scale floating tidal field. Orbital's unique floating turbine, the most powerful in the world to date, can harness underwater currents generated by tides, which can then be converted into electricity and exported to shore. Because of its predictability, tidal energy offers a reliable and consistent form of renewable energy. Tidal energy has the ability to make a cost-effective contribution to net zero transitions around the world at a utility scale."

16:13 EST Merchants Bancorp announces 3-for-2 stock split - Merchants Bancorp announced that its Board of Directors approved a 3-for-2 common stock split. Shareholders of record at the close of business on January 3, 2022 will receive one additional share of Merchants Bancorp common stock for every two shares owned. These additional shares will be distributed beginning January 17, 2022. Cash will be distributed in lieu of fractional shares based on the closing price of Merchants' common stock on Nasdaq on January 3, 2022.

16:12 EST Cisco reports Q1 adjusted gross margin 64.5% - On a non-GAAP basis, total gross margin, product gross margin, and service gross margin were 64.5%, 63.8%, and 66.5%, respectively, as compared with 65.8%, 65.3%, and 67.1%, respectively, in the first quarter of fiscal 2021.

16:10 EST American National Bankshares raises quarterly dividend 3.7% to 28c per share - American National Bankshares announced its board of directors has declared a quarterly cash dividend of 28c per common share, payable December 17 to shareholders of record December 3. The dividend amount represents a 1c per share or 3.7% increase from the prior quarter's dividend. Based on the stock's closing price of $38.70 on November 16, the dividend yield is approximately 2.9%.

16:07 EST Sonos announces $150M stock buyback - Sonos announced that its Board of Directors has authorized a common stock repurchase program of up to $150 million. Since September 2019, the company has completed $100 million in stock repurchases, including its most recent $50 million stock repurchase program which it completed in the fourth quarter of fiscal 2021. Under these prior authorizations, the company repurchased 5.2 million shares at an average price of $19.30 per share enabling the company to return capital to shareholders and offset dilution from compensation plans. Patrick Spence, Sonos CEO, commented, "We have just completed a record fiscal 2021 and are confident in the long-term growth, profit and cash generation of our model. We are committed to driving long-term shareholder value. Our strong balance sheet enables us to implement this new repurchase program while continuing to invest in our long-term roadmap and maintaining our flexibility to pursue new strategic opportunities."

16:05 EST Agilent raises quarterly dividend by 8% to 21c per share - The quarterly dividend will be paid on Jan. 26, 2022 to all shareholders of record as of the close of business on Jan. 4, 2022.

15:48 EST ATI Physical Therapy says cooperating with SEC request for documents - In a regulatory filing, ATI Physical Therapy stated that on November 5, 2021, the company received from the SEC a voluntary request for the production of documents relating to the earnings forecast and financial information referenced in the company's July 26, 2021 Form 8-K and related matters. "The company is cooperating with the SEC in connection with this request," ATI stated.

15:39 EST Blacboxstocks says no insider sales since uplisting to Nasdaq on November 10 - Blackboxstocks, a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders, addressed the recent market volatility of its common stock price following the company's NASDAQ listing on November 10, with Gust Kepler, Founder and CEO of Blackboxstocks, stating in part: "Blackbox is a company founded with the mission of providing traders and investors with real-time information and insight into the stock market. In that light, I felt that it was appropriate to address current rumors that company insiders are selling shares, or that there were large free trading positions from early Blackbox investors that were sold indiscriminately during the first week BLBX stock traded on NASDAQ... There has been no insider selling... And while I am not going to opine on the current trading dynamic of our stock or the rumors of predatory short selling in our opening week, I will simply state that we had hoped that the investors in our most recent offering had purchased their shares for long term investment purposes based on the fundamentals of our company. We remain extremely confident in our business model and are proud to be listed on NASDAQ."

14:46 EST Hemisphere Media trading resumes

14:31 EST Acceleron shareholder Avoro urges other holders not to tender into Merck offer - Avoro Capital Advisors, which together with certain of its affiliates and managed funds beneficially owns approximately 7% of Acceleron Pharma (XLRN), issued a statement reiterating why it believes that shareholders should not tender their Acceleron shares into the Merck's (MRK) tender offer for $180 per share. The firm stated in part: "As the company's third-largest shareholder, we are deeply committed to Acceleron's success and believe the company will create significant value for shareholders in the future. We continue to believe that the proposed transaction with Merck is ill-timed, undervalues the company, and is the result of a wholly inadequate process. That is why we are not going to tender our shares in support of the transaction. Others agree. Several other large, biotechnology and pharmaceutical specialist funds have publicly stated their opposition to this transaction and their intent not to tender their shares... We remain committed to assisting a standalone Acceleron succeed - including by helping to modify the composition of its Board of Directors by adding individuals with relevant experience and expertise. We urge all Acceleron shareholders not to tender into this inadequate offer and abandon the opportunity for significant future value creation."

14:03 EST Ingredion appoints chief legal officer, chief human resources officer - Ingredion (INGR) announced the appointment of two executives to its leadership team reporting to Jim Zallie, Ingredion's president and CEO. Tanya Jaeger de Foras has been named senior vice president, chief legal officer, corporate secretary and chief compliance officer, effective November 29. Prior to joining Ingredion, Jaeger de Foras was a leader in the global law department of Whirlpool (WHR), first serving as chief legal officer for its EMEA business unit since 2015 and based in Italy. In addition, Nancy Wolfe has been named senior vice president and chief human resources officer, effective January 24, 2022. Wolfe previously served in senior-level HR roles at Bayer Crop Science (BAYRY), formerly Monsanto, Ingredion stated.

13:47 EST Shift4 says not pursuing EVO Payments deal 'at this time'

13:30 EST ACI Worldwide sees FY21 operating cash flow $250M

13:29 EST Fisker reveals production-intent version of Fisker Ocean - Fisker announced that it revealed its Fisker Ocean SUV on the first media day of the Los Angeles Auto Show. The Fisker Ocean is being manufactured by Magna-Steyr at a carbon-neutral factory in Graz, Austria. The base Fisker Ocean Sport trim level is priced at $37,499, before federal and state tax credits. The Fisker Ocean Ultra is $49,999, and the Fisker Ocean Extreme is $68,999. The first 5,000 vehicles produced will be Fisker Ocean One, also priced at $68,999. Fisker estimates that the EPA range of the front-wheel-drive, single-motor Fisker Ocean Sport will be 250 miles on a single charge, the company noted. "Chairman and CEO Henrik Fisker detailed the Fisker Ocean's design philosophy and explained why it will be the most sustainable and innovative vehicle available when it starts production on Nov. 17, 2022 - exactly one year after the LA Auto Show press conference," the company noted in its press release detailing the unveiling event.

13:26 EST Moderna filed for EUA of COVID-19 booster with U.S. FDA for all adults over 18 - Moderna announced it has filed for Emergency Use Authorization, or EUA, of its COVID-19 booster vaccine at the 50 microgram dose level for all adults ages 18 and older with the U.S. Food and Drug Administration. On October 20, the FDA authorized for emergency use a booster dose of the Moderna COVID-19 vaccine at the 50 microgram dose level for people aged 65 and older; people aged 18 to 64 who are at high risk of severe COVID-19; and people aged 18 to 64 with frequent institutional or occupational exposure to SARS-CoV-2. The Moderna COVID-19 booster vaccine is authorized for adults ages 18 and above regardless of occupational risk factors in many international markets, the company said. Reference Link

12:46 EST PayPal wasn't 'even that far along in [M&A] process' with Pinterest, says CFO - PayPal (PYPL) CFO John Rainey said at the Citi Fintech Conference that the company "wasn't even that far along in the process" to buy Pinterest (PINS). The executive added that "For every deal that we announce, there's 100 that we don't look at, and the opportunity in front of us is so expansive." Rainey also said "We don't want to put our head in the sand and not explore certain other things."

12:01 EST Ecovyst falls -16.1% - Ecovyst is down -16.1%, or -$2.05 to $10.67.

12:01 EST Cato Corp. falls -18.0% - Cato Corp. is down -18.0%, or -$3.48 to $15.80.

12:00 EST Maxar Technologies rises 9.7% - Maxar Technologies is up 9.7%, or $2.99 to $33.66.

11:59 EST Apple, Google questioned by ICO over app age ratings - The U.K.'s data protection watchdog has written to Apple (AAPL) and Google (GOOGL) seeking details of how they assess apps to determine the age ratings they apply following concerns raised by an online child safety charity. In a statement today the information commissioner, Elizabeth Denham, said her office is currently conducting an "evidence gathering process to identify conformance with the code, and thus compliance with the underlying data protection law." In response to a letter from the 5Rights Foundation, Denham said "In relation to specific concerns you raised about age ratings published by online app stores, we have contacted Apple and Google to enquire about the extent to which the risks associated with the processing of personal data are a factor when determining the age rating for an app." Reference Link

11:51 EST Snap CFO: Opportunity 'intact' for 50%+ long-term revenue growth target - Comments taken from the Morgan Stanley European Technology, Media & Telecom Conference 2021.

11:49 EST Qiagen pulls back after CTFN said to push back on Thermo Fisher rumor - Shares of Qiagen (QGEN) are down about 2% in late morning trading after CTFN is said to have reported, based on its sources, that Thermo Fisher (TMO) is not currently in talks to acquire the company, contacts tell The Fly. Strength in Qiagen share yesterday had been attributed to Ben Harrington's M&A-focused Betaville blog issuing a "Rare Alert" regarding the company that, according to Bloomberg, mentioned rumors that Thermo Fisher may come back with a fresh takeover bid for its rival. Reference Link

11:27 EST MoneyGram expands mobile wallet network in Asia through bKash integration - MoneyGram International announced the expansion of its mobile wallet network through the integration with bKash, a mobile financial service provider in Bangladesh. This is the latest integration as part of MoneyGram's ongoing partnership with Thunes, a B2B company, MoneyGram said in a statement, adding that with this launch, over 55 million bKash wallet users in Bangladesh will now be able to receive funds instantly from around the world.

11:20 EST TJX: Plans to raise prices on select items 'well under way'

11:18 EST Aquila Resources shareholders approve acquisition by Gold Resource - Aquila Resources (AQARF) announced that at the company's special meeting of shareholders held earlier on Wednesday, an overwhelming majority of Aquila shareholders voted in favor of the special resolution approving the previously announced plan of arrangement pursuant to which Gold Resource Corporation (GORO) will acquire all of the issued and outstanding common shares of the company. The Transaction required the approval of (i) 66 2/3 percent of the votes cast by Aquila shareholders and (ii) a simple majority of the votes cast by the minority shareholders. Shareholders holding a total of 208,546,503 Shares were represented in person or by proxy at the Meeting. Of the votes cast at the Meeting, 98.884% were in favor of the Arrangement Resolution, the company said in a statement. Closing of the Transaction remains subject to certain closing conditions, including approval of the Ontario Superior Court of Justice. Subject to the satisfaction or waiver of the closing conditions that remain outstanding, closing of the Transaction is expected to occur in the coming weeks.

11:09 EST TJX saw consistent strength in overall comp sales every month, says CFO

11:05 EST First Financial board declares special dividend of 10c per sahre - The directors of First Financial Corporation have declared a semi-annual dividend of 53c per share payable on January 14, 2022, to shareholders of record at the close of business January 7, 2022. In addition the directors declared a special dividend of 10c per share payable on January 14, 2022 to shareholders of record at the close of business January 7, 2022.

10:54 EST NextPlay Technologies launches NextPlay X Soma Labs - NextPlay Technologies has teamed with Soma Innovation Lab and NFT Pro to launch NextPlay X Soma Labs, a digital design and innovation lab focused on developing non-fungible tokens, social games and Metaverse virtual worlds for major brands, creators and agencies. The joint venture will leverage Soma's extended reality solutions, NFT Pro's non-fungible tokens technology platform and NextPlay's proprietary in-game advertising, game development, crypto-banking, Connected TV, travel booking engine and other NextPlay digital technologies to build foundational pathways to the Metaverse. This includes travel destinations, game worlds, museums, shopping centers, stores, social clubs and more-all experienced in the Metaverse.

10:06 EST AstraZeneca's LOKELMA granted Fast Track designation - AstraZeneca has been granted Fast Track Designation in the United States for the development of LOKELMA to reduce arrhythmia-related cardiovascular outcomes in patients on chronic hemodialysis with recurrent hyperkalemia. The designation is based on the potential of LOKELMA to reduce serious adverse CV outcomes in this patient population, addressing a significant unmet medical need. This is being investigated in the ongoing Phase III DIALIZE-Outcomes trial. HK is a prevalent condition in patients with chronic kidney disease and heart failure, affecting 24% to 48% of patients with moderate to advanced CKD and/or HF, and it remains a burden once patients are on chronic hemodialysis. In patients with end-stage renal disease receiving chronic hemodialysis, HK has been associated with an increased risk of all-cause and CV mortality, and hospitalizations. The DIALIZE-Outcomes trial is part of the CRYSTALIZE evidence program, which is comprised of over 50 clinical and real-world evidence studies researching the potential benefit of LOKELMA in the management of HK across the cardiorenal spectrum. The DIALIZE-Outcomes trial is currently underway with results expected in 2024.

10:01 EST BAE Systems awarded multiple contracts from DARPA - BAE Systems has been awarded multiple development contracts from the Defense Advanced Research Projects Agency to advance quantum technology and revolutionize radio frequency sensing by breaking constraints to antenna designs that have persisted for more than a century. Leveraging quantum sensing can reduce size, and increase sensitivity and accessible bandwidth by several orders of magnitude. Awarded earlier this year, the three quantum aperture-related contracts, which total $6.5M, include work as a prime contractor on Quantum Apertures Technical Area 2 and teaming with ColdQuanta in both Technical Area 1 of Quantum Apertures and the Science of Atomic Vapors for New Technologies program.

10:00 EST Ecovyst falls -13.1% - Ecovyst is down -13.1%, or -$1.67 to $11.05.

10:00 EST UpHealth rises 8.6% - UpHealth is up 8.6%, or 27c to $3.35.

10:00 EST Despegar.com rises 11.0% - Despegar.com is up 11.0%, or $1.22 to $12.35.

09:53 EST Orbital Energy acquires Front Line Power Construction LLC for $218.4M - Orbital Energy Group announced it has acquired 100% of Front Line Power Construction LLC, a Houston-based full-service electrical infrastructure service company that has provided construction, maintenance, and emergency response services for customers since 2010. The transaction will be immediately accretive to earnings and cash flow and add significant scale to OEG, the company said in a statement. Combined company revenue for 2022 is expected to exceed $300M. Front Line will become a wholly-owned subsidiary of OEG. The senior management team, including CEO & Founder, Kurt Johnson, will remain with the company. OEG expects no organizational changes to FLP's successful, long-term operations. The Membership Unit Purchase Agreement calls for purchase of the outstanding membership interest in FLP for a gross purchase price of $218.4M. The purchase is being funded by a $105M 5-year Term Loan, 2-year restricted shares of OEG common stock, and an approximate $85M Promissory Note held by the Sellers.

09:47 EST Vtex falls -6.0% - Vtex is down -6.0%, or -94c to $14.60.

09:47 EST Stem falls -6.1% - Stem is down -6.1%, or -$1.50 to $23.17.

09:47 EST Nerdy rises 7.6% - Nerdy is up 7.6%, or 48c to $6.77.

09:47 EST UpHealth rises 8.1% - UpHealth is up 8.1%, or 25c to $3.34.

09:35 EST SS&C makes preliminary approach to acquire Blue Prism Group plc - SS&C Technologies Holdings (SSNC) confirms that it has made a preliminary approach to Blue Prism Group plc (BPRMF) regarding a possible cash offer to acquire the entire issued and to-be-issued share capital of Blue Prism for 1,200 pence per Blue Prism share. London-based Blue Prism is a company engaged in enterprise intelligent automation. SS&C's preliminary approach, which is subject to the satisfaction or waiver of a number of pre-conditions including the completion of detailed due diligence, implies an equity value of approximately $1.6B for Blue Prism. "Automation has been at the forefront of SS&C's technology initiatives for several years now," said Bill Stone, Chairman and CEO of SS&C Technologies. "Blue Prism's innovative solutions are recognized as a leader by RPA analysts, and we believe they would complement our existing products, particularly Chorus, our intelligent automation solution."

09:35 EST Lowe's says balance sheet remains 'very healthy' - Says commodity inflation did not have material impact on Q3 SSS. Says seeing some indication of early seasonal buying. Expects to absorb higher costs in distribution network going forward.

09:32 EST Stevanato Group announces expansion of corporate headquarters - Stevanato Group announced the expansion of its corporate headquarters with the construction of a new facility in Piombino Dese, Italy to advance operations and growth of the Company. The new 6,750 square meter facility is expected to support the optimization of Stevanato Group's industrial footprint, with about 2,500 square meters dedicated to increasing the production of high-value products. In addition to hosting offices, the Italian analytical services site, and R&D space, it is also expected to include new glass syringe forming lines devoted to boosting the production of EZ-fill solutions, which are pre-sterilized drug containment solutions that reduce total cost of ownership and time-to-market for pharmaceutical companies. Construction of the new building began in September 2021. The Company expects to install and validate new lines in the second quarter of 2022, and expects industrial production to begin between late second quarter and early third quarter of 2022.

09:28 EST B. Riley Principal 150 Merger up after DraftKings partners with FaZe Clan - Shares of B. Riley Principal 150 Merger (BRPM) are up about 4% to $10.80 in pre-market trading after DraftKings (DKNG) announced a new deal with FaZe Clan to become the official sports betting, iGaming, daily fantasy, and free-to-play partner of the platform. Previously, on October 25, FaZe Clan announced it has entered into a definitive merger agreement to combine with B. Riley Principal 150 Merger, a special purpose acquisition company sponsored by an affiliate of B. Riley Financial (RILY). Upon completion of the proposed business combination, BRPM will change its name to FaZe Holdings. The combined company's common stock is expected to be listed on Nasdaq under the new ticker symbol (FAZE).

09:23 EST Lowe's says Q3 results driven by disciplined execution of Total Home strategy - Says seeing strength in higher ticket categories. Says making "significant progress" in Pro sales. Says continues to "gain traction" with consumers via online platform. Says Q3 growth broad-based on two-year basis. Says ordering inventory earlier than in past years. Says current hiring environment "remains competitive." Comments taken from Q3 earnings conference call.

09:23 EST Engaged Capital sends letter to board of Quotient Technology - Engaged Capital, an investment firm specializing in enhancing the value of small and mid-cap North American equities and the owner of 6.5% of the outstanding shares of Quotient Technology, sent a letter to the Company's Board of Directors. "Dear Board Members... While we have a significant ownership position because we believe QUOT is a very valuable asset, we have become increasingly concerned with the Company's consistently poor performance, both in regards to the Company's share price and operations... In addition to the Company's operational struggles, we are alarmed by the Board of Directors' blatant disregard for good governance and dereliction of fiduciary duties to stockholders. Rather than taking decisive action to remedy the weak operating and share price underperformance, the Board has selfishly focused on employing strategies to further entrench itself... The magnitude of relative value destruction is evidence that QUOT is suffering from a company-specific problem, not an industry- or market-wide issue... Contributing to the Company's drastic underperformance, we believe, is the fact that QUOT suffers from abysmal corporate governance practices that minimize accountability and serve to entrench the existing Board and management team, including the following: Classified Board. The Board is classified into three separate classes, meaning the Company's directors are only subject to re-election by stockholders once every three years. In our view, the ability of stockholders to select directors each year is an important check on the performance of the Board... Manipulation of Director Classes. While having a classified Board is bad enough, the Board manipulated the classes on which directors serve to further limit stockholders' say on the composition of the Board... 4.9% NOL Pill. The NOL Pill entered into on November 11, 2021 effectively prohibits stockholders from acquiring 4.9% or more of the Company's outstanding shares.... Combined Chairman/CEO... No Action by Written Consent or Ability to Call Special Meetings... Supermajority Vote to Amend Bylaws and Restrictive Charter Provisions... The supermajority vote requirement significantly reduces stockholders' ability to remediate these poor corporate governance practices. Plurality Voting Standard in Uncontested Elections. The use of a plurality voting standard in uncontested elections reduces director accountability and entrenches the Board because it guarantees the election of the candidates nominated by the Board. We find these governance provisions and tactics to be self-serving and an improper use of the Company's corporate machinery to insulate the Board.

09:21 EST Chevron, Pavilion Energy and QatarEnergy publish reporting methodology - Pavilion Energy, QatarEnergy and Chevron U.S.A. (CVX) announced they have jointly published a quantification and reporting methodology to produce a statement of greenhouse gas emissions for delivered LNG cargoes. This is the first such published methodology that will be applied to sales and purchase agreements, specifically the executed SPAs by Pavilion Energy with QatarEnergy and Chevron. Intended for wide adoption, the methodology provides a calculation and reporting framework for greenhouse gas emissions from wellhead-to-discharge terminal, based on industry standards.

09:19 EST GenTech's Nature Soothie expands footprint to all Whole Foods locations in 2022 - GenTech Holdings (GTEH) is excited to announce that its recently acquired Nature Soothie line of branded herbal supplement lollipops for children will be available at all Whole Foods Market (AMZN) locations in the United States beginning in March 2022. Nature Soothie products are currently distributed through UNFI, and are available at more than 350 Sprouts Farmer's Market locations and approximately 70 Whole Foods Market locations, as well as online at NatureSoothie.com and at the Nature Soothie Amazon store. Beginning in March 2022, Nature Soothie products will be available at all 467 Whole Foods Market locations in the United States, increasing the product line's Whole Foods exposure by nearly 600%.

09:16 EST American Electric's PSO issues RFPs for renewable energy resources - Public Service Company of Oklahoma, a subsidiary of American Electric Power, submitted Requests for Proposals for renewable energy resources to supply the needs of its customers. The RFPs solicit bids for the purchase of wind energy resources of up to 2,800 megawatts (MW) and solar energy resources up to 1,350 MW. Wind energy resources must be a minimum of 100 MW and solar energy resources a minimum of 50 MW. The renewable energy resources must interconnect to the Southwest Power Pool and be located in Oklahoma, Arkansas, Kansas, Louisiana, Missouri or Texas. Proposals will be due on January 13, 2022.

09:12 EST MarketAxess adds Egypt, Hong Kong, Serbia to EM local markets offering - MarketAxess Holdings announced that it has added Egypt, Hong Kong and Serbia to its EM local markets offering. Local currency trading, which now also includes onshore Chinese debt, has grown to over $147 billion year-to-date, up 20% on the same period in the prior year. The number of active participants trading Emerging Markets debt across the MarketAxess platform also reached a record of over 1,300 firms in the third quarter. Local markets across Latin America have been particularly active on the MarketAxess platform. With a record $33.5 billion traded in the first three quarters of 2021, Mexico is the largest emerging market traded on MarketAxess. Brazil is the second largest emerging market traded on MarketAxess with $21.1 billion traded in the same period. Within Latin America, MarketAxess supports local debt trading in Argentina, Brazil, Chile, Colombia, the Dominican Republic, Mexico, Peru and Uruguay.

09:10 EST Comtech awarded $1.8M contract for RF microwave solid-state amplifiers - Comtech Telecommunications announced that during its first quarter of fiscal 2022, it was awarded an additional contract valued at $1.8M for RF microwave solid-state amplifiers from a major domestic prime contractor.

09:09 EST Capri Holdings appoints Cedric Wilmotte as interim CEO of Versace - Capri Holdings announced the appointment of Cedric Wilmotte as interim CEO of Versace, effective January 17. Wilmotte will report to John Idol, chairman and CEO of Capri Holdings. Wilmotte will serve as the interim CEO of Versace through December 31, 2022, during which time he will partner closely with Donatella Versace, chief creative officer, and the leadership team. Wilmotte brings with him many years of luxury retail experience, including a 13-year tenure with Michael Kors as the president of the EMEA region. Capri Holdings will continue to conduct a search for a permanent replacement for Jonathan Akeroyd, departing CEO of Versace, who will leave the brand on March 31, 2022.

09:07 EST Uber debuts new membership program with 'best of Uber' called Uber One - Uber Technologies announced the launch of Uber One, "a brand new membership program that brings together the best of Uber rides, delivery and groceries. As the only membership program providing discounts and exclusive experiences across both rides and delivery, Uber One is designed to help members navigate everyday life," noted the company in a statement. As Uber helps customers go anywhere and get anything, Uber One provides members with savings and an elevated experience on everyday moments. Whether it's a ride to and from work, getting dinner on the table, or stocking the refrigerator, Uber One offers member-only upgrades such as top-rated drivers on rides, premium support, and the new Uber One Promise: members get $5 in Uber Cash on eligible deliveries if our Latest Arrival estimate is wrong. For $9.99 per month or an annual price of $99.99, Uber One includes: Member pricing guaranteed with 5% off all eligible rides and 5% off eligible delivery orders on food, grocery, alcohol and more Unlimited $0 Delivery Fee on $15+ orders and $30+ grocery orders Priority service with top-rated drivers on rides and elevated member support = Uber One Promise: members get $5 in Uber Cash on eligible deliveries if our Latest Arrival estimate is wrong Exclusive access to perks like special offers and promotions, and invite-only experiences "We want our customers to experience firsthand how Uber can make their every day more effortless," said Awaneesh Verma, head of Membership at Uber. "Uber One offers elevated access to all of Uber: rides, delivery, and groceries. Members get preferred pricing, premium support, and surprise and delight perks that can make every day more fun." To join Uber One, open the Uber or Uber Eats apps. Tap on the account followed by the Uber One module. Review the benefits and Terms, tap Choose Plan and then select the monthly or annual offering. To celebrate the launch of Uber One, the annual plan will be offered at a special price of $49.99, which is 50% off the regular annual plan price, from November 17-29.

09:06 EST Kelso Technologies announces development partners for KIQ X Industries - Kelso Technologies reports that the Company's wholly owned subsidiary KIQ X Industries has secured two key prototype development partners in its KXI Wildertec Heavy Duty Suspension project. Vector Truck Designs and Kinetic Drive Solutions have been contracted by KIQX to provide a team of automotive engineers, control system designers and software specialists that can guide KIQX to a regulatory compliant final production-ready HD prototype. Design ambitions are to meet the needs of the Company's target markets with technological performance that can deliver new standards for safety and efficiency while providing environmental and cultural responsibility for vocational wilderness transportation applications. Vector will lead the project in final stage prototype design and development of all mechanical components. With deep roots in OEM design, Vector has been building heavy duty vehicle suspensions for the world's top companies for decades. Vector is fully qualified to build KXI to meet the rigorous standards for regulatory compliance, performance and dependability. KDS joins KIQX as a specialist engineering partner who can lead to the development and completion of an integrated suspension control system for the HD prototype. The KDS design team brings a wealth of experience in control system development integrating ride height, stability, central tire inflation systems, rear steering functions featuring intelligent computerized vehicle control systems. KDS is a respected and accredited service and product provider of mission critical mobility systems to elite organizations across the globe. The prototype vehicle, when completed will go through extensive engineering integrity and Canadian Motor Vehicle Safety Standards compliance testing. This is to ensure that equipment operators are able to utilize the full efficiency of the KXI technology without compromising the safety of the occupants or the general public. COVID-19 has created many supply chain issues in the automotive industries but the completion of the prototype is expected in the second quarter of 2022.

09:04 EST Benefitfocus acquires Tango Health, transaction to close during Q4 - Benefitfocu, announced it has acquired Tango Health, a software and services company offering Affordable Care Act, ACA, compliance and benefit decision support solutions. The acquisition of Tango Health enables Benefitfocus to offer its customers ACA compliance and reporting solution. "The burden on employers is greater than ever as the health care industry continues to evolve and compliance requirements become increasingly complex and costly for employers to manage. We are committed to helping our customers manage these complexities through comprehensive administrative capabilities underpinned with service excellence," said Matt Levin, president and CEO of Benefitfocus. "Consistent with our strategy to strengthen the foundation of our core offerings, the acquisition of Tango Health enables us to offer our customers an industry-leading ACA compliance and reporting solution to complement their overall benefits strategy. We are excited to extend this best-in-class solution to our customers and welcome this accomplished and experienced team to the Benefitfocus family." The immediate priority for both organizations is to continue to support existing customers, as both companies enter the ACA reporting season. Existing Tango Health and Benefitfocus customers can expect continuity and for the two organizations to operate business as usual in delivering against their customer commitments. The transaction is subject to customary closing conditions and is expected to close during the fourth quarter.

09:03 EST Bel Fuse retains Three Part Advisors as investor relations counsel - Bel Fuse announced it has retained Three Part Advisors, LLC, a rapidly growing, full-service investor relations consulting firm. Three Part Advisors will work directly with management to develop and execute a comprehensive, strategic investor relations program that focuses on educating investors and increasing exposure within the investment community. In addition to providing investor relations consulting services, Three Part Advisors also produces IDEAS Conferences, which are annual independent regional investor conferences that attract more than 150 quality presenting companies and more than 1,000 investors and analysts annually.

09:02 EST SQUID chooses Outbrain to monetize personal news feed - Outbrain announced the renewal of its partnership with SQUID, a mobile-first personalized news service and application powering news for platforms including Huawei's browser, to drive mobile-service monetization through Outbrain's promoted recommendations. Through this partnership, SQUID will gain access to advertising revenue from Outbrain's global network of 20,000+ native advertisers running promoted recommendation campaigns on Outbrain. Together with SQUID, Outbrain's promoted recommendations will offer relevant, non-intrusive native advertising experiences to users creating personalized news feeds and sharing instantly across social platforms. With average Click-through-Rates of 3-4%, Outbrain's network will aid SQUID's monetization across Android and iOS applications, as well as its integrations on -1 pages, browser, assistant, search and other pre-installed experiences.

08:59 EST Hims & Hers to offer products on Amazon - Hims & Hers (HIMS) announced it will start offering its products in Amazon's (AMZN) store to increase the accessibility of Hims & Hers supplements, sexual health and wellness products and hair care offerings, including a few product bundles exclusively available through the new official Hims & Hers store on Amazon.com.

08:53 EST Santander Chile holds ESG talk with investors - For the second year in a row, Santander Chile held a virtual event with investors, where the advances of the Bank were explained by Claudio Melandri, President of the Bank, and its CEO, Miguel Mata. In this opportunity, the focus was ESG themes, highlighting the efforts Santander has done to help its clients transition towards a greener economy and how it has reduced its own impact on the planet. The company said, "The Bank is currently preparing its first ESG Framework which should be launched soon. Under this mechanism, the bond issues will have an official seal as ESG bonds. This framework will include a Second Party Opinion to ensure that funds will be allocated to projects, complying with the principles of the International Capital Markets Association. Initially, US$1.5 billion in initiatives have been identified that will be financed through this program. The ESG bonds will be linked to energy efficiency, renewable energy, pollution reduction, financial inclusion, and social projects. Miguel Mata announced the ten responsible banking commitments that we have established to meet in the coming years: To be the best company to work for in Chile: we are currently the number 1 company in the Great Place To Work ranking in 2020 in companies with more than 1,000 workers and we have the Top Employer certification. We seek to maintain this leadership position. Increase the percentage of women in managerial positions: currently 25% of managers are women and our goal is to reach 30% by 2025. Eliminate the gender pay gap: we currently have a 3.1% gender pay gap and our goal is to eliminate it by 2025. The Equal Conciliation Seal, delivered by the Ministry of Women and Gender Equity, gives us a path and an official commitment to advance on this issue. Work to financially empower people: between 2019 and 2020 we contributed to financially empower 921,779 people. Through our financial products such as Life we want to financially empower more than 2 million people by 2025. Grant green financing to our clients: We have defined a goal for 2025 to finance our own projects and those of our clients for at least US$ 1.5 billion through our ESG framework. Increase energy from renewable sources: 28% of our energy comes from these types of sources. In addition, we are committed to ensuring that 100% of the electrical energy we use comes from renewable sources. Mitigate 100% of our carbon footprint and gradually reduce it: since 2019 we mitigate 100% of our carbon footprint. We will also continue to make progress in measuring the carbon footprint of our loan portfolio and we join the Group's goal of becoming carbon neutral by 2050. Regarding our own operations, the goal is to be carbon neutral by 2025, without the need to offset the footprint with the purchase of carbon credits. Eliminate single-use plastics in our operation: This year we will eliminate 100% of single-use plastics. Deliver scholarships, internships and entrepreneurship programs: in 2020 we awarded 2,951 scholarships for education and entrepreneurship at the local level. Our goal is to award 13,541 scholarships between 2019 and 2024. Support people through our community contribution programs: during 2020 we supported 103,792 people through our education programs and other support measures for the benefit of people in vulnerable situations. In social matters between 2019 and 2024 we hope to help 493,852 people through our community programs. We also want to continue generating ROE at 17% -19% with core capital levels above 10% in BIS III."

08:44 EST Target CFO: Some cost pressures temporary, some lasting longer

08:40 EST Target sees FY operating margin rate of 8% or higher

08:39 EST SharpLink Gaming announces pricing of $10M registered direct offering - SharpLink Gaming announced it has entered into a securities purchase agreement with an institutional investment firm, which is an existing SharpLink shareholder. Pursuant to the agreement, the Investor is purchasing 1,413,075 of the Company's ordinary shares at a purchase price of $3.75 per share and pre-funded a warrant to purchase up to 1,253,592 ordinary shares at a funding amount of $3.74 per share and an exercise price of $0.01 per share, for gross proceeds of $10 million. SharpLink expects the net proceeds from the offering to be approximately $9.9 million after deducting approximately $100,000 in offering expenses. The Company expects to use the net proceeds for supporting its technology and business development initiatives, as well as for general working capital purposes. The offering is expected to close on or about November 19, 2021, subject to the satisfaction of customary closing conditions. In a concurrent private placement, the Investor will purchase a warrant to purchase an additional 2,666,667 shares at an exercise price of $4.50 per share, which, if exercised, will result in gross proceeds to the Company of $12.15 million. The additional warrants will be exercisable beginning six-months after closing and ending on the fourth anniversary of closing

08:38 EST HP Inc. appoints Kim Rucker to board of directors - HP (HPE) announced the appointment of Kim Rucker to its board of directors. Rucker is the former executive vice president, general counsel and secretary of Andeavor, which was acquired by Marathon Petroleum (MPC) in 2018. Rucker is a member of the boards of directors for Marathon Petroleum Corporation as well as several other companies. Additionally, she is on the board of directors of Haven for Hope and a member of the board of trustees of Johns Hopkins Medicine.

08:36 EST Mullen Automotive to debut FIVE EV crossover SUV at LAIAS - Mullen Automotive announced that the Company will be debuting the FIVE EV Crossover SUV to the world today for the first time at the Los Angeles International Auto Show and that the FIVE is a finalist for the LAIAS ZEVAS Award for the "Top SUV Zero Emission Vehicle." The FIVE debut will take place today at 1:50 p.m. on the main stage in the south hall of the Los Angeles Convention Center. The FIVE will continue to be on display in the South Hall during the consumer days of the show, Nov. 19-28, 2021.

08:35 EST Sarepta Merck appoints Stephen Mayo to board of directors - Sarepta Therapeutics (SRPT) announced the appointment of Stephen Mayo, Ph.D., to its Board of Directors, effective immediately. Mayo is currently the Bren Professor of Biology and Chemistry at California Institute of Technology, and serves on the board of directors for Merck (MRK) and on the scientific advisory board of Rubryc Therapeutics

08:35 EST Alcoa purchases group annuity contracts with $1B of assets associated - Alcoa (AA) announced the purchase of group annuity contracts that will facilitate the transfer of approximately $1B of pension obligations and assets associated with defined benefit pension plans for certain United States retirees and beneficiaries. The transfer, which will be complete later this month, will further enhance Alcoa's balance sheet, reduce the risk from volatility in pension plan obligations, and continue to meet commitments to retirees and beneficiaries. The group annuity contracts will be executed by two subsidiaries of Athene Holding (ATH). Athene will assume payments for approximately 11,200 participants in the U.S. pension plans. Participants will not have any change in their benefits, and Athene will take over payment obligations in December. Athene, through its subsidiaries, is a leading retirement services company with total assets of $224.4B as of September 30. With operations in the United States, Bermuda and Canada, Athene specializes in helping its customers achieve financial security and is a solutions provider to institutions. In Q4 of 2021, Alcoa expects to record a non-cash settlement charge of approximately $565M, or $2.96 per share related to the annuity transaction. The company's remaining U.S. defined benefit pension plans are expected to be greater than 95% funded after the transfer is complete.

08:34 EST Streamline Health announces KLAS Research's First Look Report - Streamline Health Solutions announced that KLAS Research completed and published a First Look Report on eValuator technology and the results Streamline customers are experiencing. KLAS is a leading healthcare IT research firm that provides transparent and impartial insights. Its First Look report reveals an unbiased view of how the eValuator solution improves coding accuracy and financial performance by analyzing all coded records before being billed. KLAS surveyed customers at standalone hospitals, academic medical centers and small-hospital health systems and found that: 100% of customers saw outcomes within 6 months, with 33% of those seeing outcomes immediately;100% of customers would buy it again; and customers praise eValuator's robust rule sets and targeted reporting and see Streamline Health as willing to engage on opportunities to enhance the system. In all four key performance areas, Streamline customers gave eValuator all A's and one' B+.

08:32 EST Southwest Gas: HSR period expires in connection with Questar acquisition - Southwest Gas Holdings (SWX) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired at 11:59 p.m. EST on November 15, in connection with the company's pending acquisition of Dominion Energy (D) Questar Pipeline its subsidiaries and certain associated affiliates, including Overthrust Pipeline, White River Hub and Questar Field Services from Dominion Energy. The expiration of the HSR Act waiting period satisfies one of the conditions to the closing of the pending acquisition. The transaction is expected to close on or before December 31, 2021, subject to the satisfaction of other customary closing conditions.

08:32 EST Denali Therapeutics announces Takeda to exercise option to co-develop DNL593 - Denali Therapeutics (DNLI) announced that its strategic partner Takeda Pharmaceutical Company (TAK) has exercised an option, pursuant to an existing collaboration agreement between the two companies, to co-develop and co-commercialize DNL593, an investigational, brain-penetrant progranulin replacement therapy for the potential treatment of frontotemporal dementia-granulin, FTD-GRN. "We are excited to advance our collaboration with Takeda on the development of DNL593 as a potential treatment for people with FTD-GRN," said Denali's Chief Executive Officer, Ryan Watts, Ph.D. "Pending acceptance of regulatory submissions, DNL593 will be the sixth therapeutic candidate from our broad pipeline, and our second Transport Vehicle-enabled molecule, in clinical development. This progress underscores the potential of our TV platform technology, which is designed to enable and enhance delivery of biologic therapeutics to the brain for the treatment of neurodegenerative diseases."

08:30 EST Diana Shipping extends distribution data for OceanPal spin-off - Diana Shipping announced that the distribution date for the previously announced spin-off of its wholly-owned subsidiary, OceanPal Inc., has been extended. The new distribution date, to be announced in a separate press release, is expected to occur as soon as practicable following the effectiveness of the OceanPal Inc. registration statement under the Securities Exchange Act of 1934 on Form 20-F filed with the U.S. Securities and Exchange Commission (the "Registration Statement"). The Company expects the spin-off transaction to be consummated in approximately two weeks on the same terms and conditions as previously announced in the Company's press release dated October 26, 2021 and in the Registration Statement, which has not yet become effective. The record date of the OceanPal Inc. spin-off will not change

08:29 EST Newcrest Mining to begin drilling at Cornerstone's Miocene project - Cornerstone Capital Resources announced that Newcrest International will begin a reverse circulation drill program at Cornerstone's Miocene gold-copper project in Chile in January. Highlights: Two sizeable prospective target areas defined. Three individual drill targets outlined at the Cerros Bayos target area. Base camp established in the vicinity of the Project area. Newcrest is operator of the Project and has retained Major Drilling who will be mobilizing a drill rig to site. Drilling of the first hole MIO0001 expected to begin in January. Results of the first hole will determine the location of subsequent holes. The Project is in the Regions of Atacama and Antofagasta of northern Chile, about 230km south of the city of Antofagasta at 4000 masl and is targeting High Sulfidation epithermal gold-silver and porphyry gold-copper deposits along the interpreted northern extension of the Maricunga magmatic belt which hosts several world-class gold deposits. The Miocene claims were selected using a proprietary data base licensed exclusively to Cornerstone, and offer excellent potential for discovery. The property has never been drilled. Significant epithermal mineralization has been discovered on neighboring properties along strike to the west of the Miocene property. On December 7, 2018, Newcrest and Cornerstone signed a farm-in agreement granting Newcrest the option to earn up to a 75% interest in the Project in stages. Exploration work carried out by Cornerstone previous to the Farm-In Agreement consisted largely of geochemistry work, a ground magnetic survey, prospecting, geological mapping and spectrometry work to define and prioritize exploration targets to be drill-tested. Geology work shows two sub-parallel NW-SE oriented altered / anomalous regional trends affecting the volcanic units. Alteration minerals and 3D distribution patterns along this trend are typical of high sulphidation epithermal systems. Altered and geochemically anomalous areas up to 9km by 3km in size have never been trenched nor drill tested. Following the signing of the Farm-In Agreement, Newcrest carried out geochem sampling, 1:5,000 geological mapping, 6 E-W oriented CSAMT geophysical survey lines, petrography and spectrometry work on rock and soil samples, age dating, data integration and modelling, redefining the two previously identified, sub-parallel prospective zones: Cerros Bayos and Llano Blanco, to a minimal size of 8 by 1.5 km. Further detailed work will focus on the Cerros Bayos target area, outlining three individual zones: Bloque Oeste, Bloque Central and Bloque Este, separated by NE oriented normal faults. Preliminary drill targets are defined on each of these blocks, to test blind precious and metals mineralization at relatively shallow depth. Targeting is made based on geology and structures, size, type and intensity of epithermal alterations, presence of pathfinder elements, and resistivity zones mapped at depth by CSAMT survey. Bloque Este will be drilled first. Newcrest has completed its initial minimum work commitment of $1.1M at the Project and elected to exercise its option to advance to Stage 1 under the Farm-in Agreement.

08:26 EST Wipro, Ikon Science enter strategic partnership - Ikon Science announced a collaboration with Wipro that will enable companies to accelerate their digital transformation even if they use legacy databases by leveraging Curate, Ikon's scalable, cloud-enabled subsurface knowledge management solution. Digital transformation initiatives often compromise end users by creating siloed data and complexity. The partnership between Ikon Science and Wipro addresses this by using Curate as the focal point of a comprehensive and scalable digital transformation solution.

08:25 EST Target methodically working around supply chain challeges, says COO Mulligan - COO John Mulligan says Target's supply chain team has been methodically working around challenges throughout the network to ensure products reach the shelf at the right time. "We're entering the holidays with a very healthy inventory position," Mulligan comments.

08:23 EST Patriot One Technologies introduces solutions, capabilities on Platform - Patriot One Technologies announced a new set of solutions and capabilities built on its artificial intelligence -powered Platform, which will give security venue operators a new way to make data-driven, intelligent decisions about overall security requirements and vulnerabilities. By using real-time, easily accessed statistics, Facility Reporting, Facility Insights and Customizable Alerting will provide a holistic view of the venue, enabling operators to optimize staffing and tailor the solution to their unique needs to protect patrons and staff, and enhance the overall patron experience. Today marks the first of several releases to the Platform, which integrates Patriot One's next-generation patron screening solutions, Multi-Sensor Gateway and Video Recognition System. Patriot One will demo the new capabilities at ISC East in New York City on November 17th and 18th; visit them at booth #937 for more information.

08:22 EST Freshworks community builds new capabilities for app - Freshworks announced the winners of the Freshworks Refresh App Challenge at its annual user conference Refresh. The week-long hackathon included more than 300 customers, partners, and independent developers competing for the best new application in the Freshworks Marketplace. The winners of the Refresh App Challenge join 1,200 public applications available to Freshworks' growing community of 52,000 customers. The Refresh App Challenge offered developers the opportunity to invent fresh ideas to make work easier and more delightful for customer support agents and IT service managers to serve their customers. Team Handyman and Team Schedule Reply were the winners of the competition. Team Handyman's app powers collaboration and productivity while Team Schedule Reply's app improves automation and proactive issues resolution. Team Handyman developer Harish Kotra built a set of tools packed into one app that improves the productivity of customer service agents using Freshdesk to help address issues faster. Team Schedule Reply members Sushant Awalekar and Vishwajeet Singh created a new app that enables agents to schedule replies to customers so agents can better manage their workloads and their customers' expectations. Freshworks continues to enhance the capabilities of the Freshworks Neo platform.

08:19 EST Sight Sciences announces publication of data on MGS using OMNI Surgical System - Sight Sciences announced publication in Clinical Ophthalmology of favorable data showing that microinvasive glaucoma surgery, MIGS, using the OMNI Surgical System suppressed daily fluctuations in intraocular pressure, IOP. OMNI is cleared by the U.S. Food and Drug Administration and CE-Marked for canaloplasty followed by trabeculotomy. Sight Sciences intends to further develop OMNI and seek regulatory clearance for expanded indications. The importance of IOP reduction to limit or halt disease progression is well known and has been demonstrated in studies such as the Advanced Glaucoma Intervention Study, AGIS, and the Early Manifest Glaucoma Trial, EMGT. The importance of daily IOP fluctuation in glaucoma progression is also generally accepted. Results from the GEMINI study showed that MIGS using the OMNI Surgical System resulted in a significant reduction in overall mean IOP from baseline, and in a post hoc analysis, a reduction in the variation and amplitude of mean IOP was observed at each diurnal time point evaluated. "We believe this post hoc analysis of the GEMINI study is meaningful because it shows that OMNI not only lowers IOP by addressing all three points of resistance in the conventional pathway, but treatment with OMNI also decreased the magnitude of daily IOP fluctuations, known to be a significant and independent risk factor for disease progression," said Paul Badawi, Co-Founder and CEO, Sight Sciences. "OMNI uniquely enables clinicians to perform canaloplasty followed by trabeculotomy and address all three points of resistance in the diseased conventional outflow pathway with a single device through a single clear corneal microincision. We believe, with this post hoc analysis, we are the first company to observe a 'flattened diurnal curve,' an important clinical finding that further supports OMNI's differentiated clinical outcomes and our forward-thinking leadership in the MIGS category."

08:16 EST Moderna files for Health Canada authorization of COVID-19 vaccine in children - Moderna announced that it has submitted for authorization with Health Canada for the evaluation of a 50 microgram two-dose series of SPIKEVAX in children ages 6 to 11 years.

08:14 EST Pasithea Therapeutics launches in-home intravenous ketamine therapy - Pasithea Therapeutics announced that its wholly owned subsidiary, Pasithea Clinics, commenced clinical operations, offering in-home intravenous ketamine therapy to patients suffering from treatment-resistant mental health issues. Initially, the treatment will be offered in New York City, Los Angeles, San Diego, and San Francisco and will expand nationwide in the coming months. Patients with mental health disorders often struggle to complete day-to-day activities, and even small tasks can take extra effort. In disorders such as depression and post-traumatic stress disorder, symptoms such as fatigue, social isolation, lack of motivation, and high levels of anxiety are frequent. The effort to go to a physical clinic can be overwhelming. By providing this treatment at the patient's home, Pasithea aims to broaden access to this important therapy. Ketamine is a U.S. Food and Drug Administration approved drug introduced to the medical community as an anesthetic more than 50 years ago. It has recently been repurposed for the treatment of psychiatric disorders using significantly lower doses than in anesthesia and is now gaining ground as a promising treatment for mental health disorders. In certain psychiatric conditions, such as treatment-resistant depression and post-traumatic stress disorder, it has shown remarkable efficacy and a rapid and sustained effect, and up to 70% of those who receive this treatment can eventually show a clinical response. While the number of treatments suggested is done on a case-by-case basis, a typical treatment plan consists of up to six infusions in the interval of two to three weeks.

08:14 EST Dermata announces 1st patient enrolled in Phase 2 Trial of DMT310 for rosacea - Dermata Therapeutics announced it has enrolled the first patient in its Phase 2 trial of DMT310 for the once-weekly treatment of moderate-to-severe rosacea. DMT310 is Dermata's lead product candidate, consisting of a once-weekly topical treatment with both mechanical and chemical mechanisms of action, currently being investigated to treat multiple inflammatory skin conditions, including rosacea, acne, and psoriasis. "We are excited to enroll the first patient in our Phase 2 trial of DMT310 for the treatment of moderate-to-severe rosacea and believe that due to the similarities between rosacea and acne we may see a similar reduction of inflammatory lesions in rosacea that we previously saw in our DMT310 Phase 2 acne trial," commented Christopher Nardo, Ph.D., Dermata's Senior Vice President of Development. "Additionally, based on in vitro data we have generated, DMT310 inhibits the production of IL-17, which we believe to be a cytokine that plays a role in the inflammatory pathway of rosacea. The downregulation of IL-17 coupled with the mechanical actions of DMT310's spicules could make DMT310, if approved, the first once-weekly topical product candidate to help treat the multiple symptoms of rosacea." "This Phase 2 trial has the potential to reinforce the unique treatment effect of DMT310, and its ability to treat a variety of inflammatory skin conditions with once-weekly topical applications, unlike anything currently available on the market," stated Gerry Proehl, Dermata's Chairman, President, and Chief Executive Officer. "One of our core objectives at Dermata is to change how patients treat their skin conditions by providing them with unique and differentiated dermatology products in areas where there remains a high unmet need."

08:12 EST Jowell Global enters strategic cooperation with Unilever's Uni-Excubator - Jowell Global (JWEL) announced that Jowell Global and Unilever's (UN, UL) Uni-Excubator held a strategic cooperation conference at the Longrich China headquarters on October 22,2021. Mr. Zhiwei Xu, Chairman of Jowell Global, and Mr. Jun Fang, Vice President of Data and Digital Development of Unilever China, were in attendance. During the conference, Jowell Global and Unilever's Uni-Excubator jointly announced their strategic cooperation in China's new social media retail. The cooperation will start with Unilever's Hazeline Snow product line to be sold on the Company's e-commerce platform to accelerate its reach in the domestic scented body care market, and enhance Hazeline Snow to upgrade the customized skin care solution for the consumers in Chinese market. Uni-Excubator is Unilever's initiative to partner with startup brands in China to incubate and scale their development, using an innovative model of "Chinese Innovation with Global Support". The initiative seeks out opportunities for new brands through open innovation and leverages Unilever's marketing prowess, wide-spread channels, R&D, and supply chain capabilities.

08:08 EST Target CEO: Many vendors have raised prices

08:07 EST HTG, Icahn School of Medicine enter bladder cancer research collaboration - HTG Molecular Diagnostics and the Icahn School of Medicine at Mount Sinai, announced they have entered into a new research collaboration as part of HTG's Transcriptome Panel Early Adopter Program. HTG will provide in-kind laboratory services utilizing its proprietary HTG EdgeSeq technology in connection with multiple Icahn Mount Sinai bladder cancer studies. Launched in August 2021, HTG's Transcriptome Panel, is designed to measure approximately 20,000 mRNA targets using the HTG EdgeSeq technology. HTG's panel reduces sample input requirements, is less sensitive to sample age, provides for faster turnaround times than other currently available methods and has a higher sample success rate than RNA-Seq for gene expression profiling. The collaboration between HTG and Icahn Mount Sinai involves three separate clinical study cohorts focused on bladder cancer. The first project includes approximately 160 non-muscle-invasive bladder samples from cancer patients treated at hospitals across Sweden and were part of the "25-year-follow-up of the 1995-1996 Stockholm bladder cancer" project. Utilizing the HTG Transcriptome Panel, Icahn Mount Sinai will examine treatment-naive samples for transcriptional signatures that could be used to potentially predict treatment outcomes and long-term survival. The second project includes muscle-invasive bladder cancer samples from patients treated with immune checkpoint blockade immunotherapies at hospitals across the United States. From this study, pre-treatment trans-urethral resections of bladder tumors from 108 patients will be assessed with the HTG Transcriptome Panel, with the goal of identifying transcriptional signatures that may predict treatment response or treatment failure. The third project includes MIBC samples from patients treated with chemotherapy along with PD-1 blockade as a potential bladder-sparing approach. Data from the HTG Transcriptome Panel of TURBTs from 68 patients will be evaluated with the goal of identifying transcriptional signatures that may predict treatment response or treatment failure as part of a bladder sparing treatment protocol.

08:07 EST Singing Machine partners with Honky Party Express, launches Carpool Karaoke - The Singing Machine Company announced the successful launch of its new Carpool Karaoke Party Bus which has recently hit the streets of Nashville, TN. "The CARPOOL KARAOKE segment is the biggest viral video hit ever on late-night television, with over 4 billion views on YouTube since its inception. Guests boarding the Carpool Karaoke Mic branded bus can enjoy a fun night out in Nashville, reinforcing the image that our Mic is synonymous with a good time. This partnership demonstrates our strong focus on an omni-channel marketing approach. Aside from being seen by millions across Nashville, the branded bus will be visible by thousands of people through social media, making the audience we are targeting both timeless and infinite," added Atkinson.

08:05 EST IVECO to supply 1,064 gas-powered S-WAY trucks to Amazon - IVECO, a brand of CNH Industrial (CNHI), announced an important development in its commercial relation with Amazon. Amazon (AMZN) has already taken delivery of the first batch of 216 units IVECO S-WAY CNG, Compressed Natural Gas, to be operated by its partners in Europe and another 848 units have been ordered with deliveries to be started in the middle of 2022, for a total order of 1,064 trucks. These 1,064 trucks are powered by the state-of-the-art FPT Industrial Cursor 13 Natural Gas engines and equipped with 1052-liter CNG tanks. Gerrit Marx, designated Chief Executive Officer of Iveco Group, said: "We have been pioneering gas propulsion technology for 25 years, developing solutions that allow operators to make significant reductions in emissions right now. Collaboration with global leaders like Amazon is a testament to the robust capability of our innovative products and our unyielding commitment to the industry objective of decarbonizing transport by 2050. Iveco Group will continue leading the way in combustion engines running on renewable fuels, the only viable solution already available at scale on the market to reduce emissions. Let's not forget that a CNG truck powered by bio-methane can cut CO2 emissions by up to 95% from a well-to-wheel CO2 measuring approach, effectively contributing to the decarbonization process."

08:05 EST MSG Sports, MSG Entertainment announce marketing partnership with Infosys - Madison Square Garden Sports (MSGS), Madison Square Garden Entertainment (MSGE) and Infosys (INFY) announced a multi-year signature marketing partnership making Infosys the official digital innovation partner of key MSG properties including the New York Knicks, New York Rangers and the Madison Square Garden Arena. As part of this collaboration, MSG Entertainment and Infosys will create a digital command center inside The Garden, featuring Infosys' service and technology platforms. Through the continuous production of data and analytics, the command center will provide on-site staff with enhanced, real-time oversight of event operations.

08:03 EST Target CEO: Same-day services propelled digital growth in Q3 - Comments taken from Q3 earnings conference call.

08:01 EST Orange Bank & Trust Company selects BIO-key's PortalGuard IDaaS platform - BIO-key International announced Orange Bank & Trust Company, headquartered in Middletown, NY, has selected BIO-key's PortalGuard Identity-as-a-Service platform, including WEB-key biometric authentication to enhance access security to enterprise applications and bank workstations. With $1.9B in total assets and 14 locations across the Hudson Valley, Rockland and Westchester counties, Orange Bank is a leading regional provider of banking and financial services, including commercial lending, cash management, and wealth management services.

07:57 EST Science 37 publishes data on shift in clinical research industry - Science 37 Holdings has published new data suggesting that the clinical research industry has reached a pivotal shift in the way that clinical trials are conducted, as Sponsors and CROs report they plan to run more agile clinical trials in 2022 than traditional, site-based studies. Findings are the result of a sentiment study among 127 senior clinical research executives in September and October 2021. Nearly eight of 10 respondents said they plan to run an agile clinical trial in the next 12 months. Conversely, just seven of 10 said they are planning to run a traditional, site-based study in the next 12 months. In addition to documenting this fundamental shift, the survey data also paints a vivid picture of the decentralized clinical trial landscape for the year ahead, suggesting significant increases in DCT activity across multiple therapeutic areas and study phases. Among the findings: 46% of respondents expect to run an oncology study utilizing DCT in the next year, vs. 35% for the previous year-making oncology the most prevalent DCT category. Oncology, CNS, rare diseases, and immunology should see the biggest uptake in DCT use. The report suggests significant increases in DCT activity across Phase II, III, and IV studies. The company also expects to see big increases in the deployment of most individual DCT components, particularly eConsent, telemedicine, mobile nurses, and remote sites in a hybrid model. The top-3 perceived benefits of DCT are better patient experience, better patient retention, and faster recruitment. The top-3 perceived challenges of DCT are integrating traditional sites with DCT, lack of in-house capabilities, and regulatory concerns.

07:44 EST TJX reports quarter-to-date open-only comp store sales up mid-teens - For the start of the fourth quarter of Fiscal 2022, overall open-only comp store sales growth is up mid-teens over the fourth quarter of Fiscal 2020. Due to the continued uncertainty of the current environment with the COVID-19 global pandemic, the company is not providing financial guidance at this time.

07:39 EST The Very Good Food Company reports October sales C$1.5M - The Very Good Food Company shared its record performance in the month of October. With sales of approximately C$1.5M for the month, the company saw an increase of 202% in revenue compared to the same month last year. The company said, "Record sales of C$1.5 million were achieved in October due to increased demand for VERY GOOD's products in both its wholesale and eCommerce channels. The Company recently launched into U.S. retail in August 2021 and was in over 396 stores in the U.S., in addition to 805 stores in Canada at the end of September. eCommerce sales also rose due to the demand for holiday products including the Stuffed Beast and the limited-edition Thanksgiving Box. In October, Stuffed Beast sales were seven times the number sold in October of last year. These increased listings across the U.S. and Canada and demand for vegan meat alternatives for the holidays drove revenue in October to twice that of the same month in 2020. VERY GOOD plans to introduce additional Holiday Boxes before the festive season."

07:38 EST Lowe's sees FY21 CapEx up to $2B

07:37 EST Lowe's expects 2021 share repurchases of $12B - During the quarter, the company repurchased 13.7M shares for $2.9B and paid $563M in dividends. Given its better-than-expected performance, the company now plans to repurchase approximately $3B in shares in the fourth quarter, bringing the expected total share repurchases for the year to approximately $12B. This incremental share repurchase is consistent with the company's long-term commitment to returning excess capital to shareholders.

07:34 EST Abeona Therapeutics to present on Transpher A study of ABO-102 - Abeona Therapeutics announced that information about the company's ABO-102 pivotal Transpher A study in Sanfilippo syndrome type A will be presented at the 14th International Congress of Inborn Errors of Metabolism. The meeting will take place virtually and at the Hilton Sydney in Sydney, Australia on November 21-23, 2021. The oral presentation titled, "Interim results of Transpher A, a multicenter, single-dose, phase 1/2 clinical trial of ABO-102 gene therapy for Sanfilippo syndrome type A," will be presented by Dr. Nicholas Smith, Department of Neurology and Clinical Neurophysiology, Women's and Children's Hospital. The presentation includes new data characterizing the positive correlational relationship between the Bayley Scales of Infant and Toddler Development and the Mullen Scales of Early Learning. standardized measures of non-verbal cognitive functioning for young children, and previously announced efficacy and safety data on Abeona's AAV-based gene therapy, ABO-102. The presentation will take place during a session on Tuesday, November 23, 2021 from 11:45 am-1:15 pm Australian Eastern Daylight Time.

07:33 EST Mirati Therapeutics submits IND application to FDA for MRTX1719 - Mirati Therapeutics announced that it has submitted an Investigational New Drug application to the U.S. FDA to evaluate the company's synthetic lethal PRMT5 inhibitor, MRTX1719, for the treatment of methylthioadenosine phosphoylase-deleted cancers. The Phase 1/2 clinical development strategy for MRTX1719 is designed to establish a Phase 2 dose and assess the safety, pharmacokinetics and initial clinical activity of MRTX1719 in patients with MTAP-deleted cancers. The company expects to initiate a Phase 1/2 clinical trial in the first quarter of 2022, pending IND clearance from the FDA.

07:32 EST Sportradar, NBA announce long-term global partnership - The National Basketball Association, NBA, and Sportradar announced an expansive multiyear partnership agreement that will see the NBA, Women's National Basketball Association, WNBA, and NBA G League use Sportradar's global capabilities to grow U.S. operations, increase their international footprint, and drive fan engagement. This new partnership begins with the 2023-24 NBA season and provides the NBA with an equity stake in Sportradar. This agreement with the NBA, WNBA and NBA G League maintains Sportradar as the exclusive provider of NBA data worldwide that will help fans across the globe engage with the three leagues. In addition, the new relationship includes expanded distribution rights regarding the use of player tracking data. "We are delighted that the NBA has chosen Sportradar as the Official Partner who can support the global popularity and explosive growth of the game," said Carsten Koerl, global CEO, Sportradar. "Basketball is the largest U.S. sport in the world by popularity and, as a market leader, we are best positioned with the technological expertise and industry relationships to help the NBA entertain fans globally." Continued Koerl: "We believe that this agreement will contribute to Sportradar's profitable business and continued growth. The remaining time left on the existing deal, and this new multi-year agreement, gives us significant runway to partner with the NBA and develop exciting solutions across our teams, betting and sports entertainment verticals." This deal extends a relationship that began in 2016, when Sportradar and the NBA announced a multiyear partnership, which made Sportradar an Official Provider of Real-time NBA League Statistics.

07:19 EST Kintavar says IAMGold commences drilling on Anik Gold Project - Kintavar Exploration is very pleased to announce that IAMGOLD Corporation has begun drilling on the Anik Gold Project in the Chapais-Chibougamau region of Quebec. The Project has been optioned out to IAMGOLD where it can earn in up to 80% interest. IAMGOLD is evaluating several potential gold zones on the Project which have been highlighted by previous Kintavar work and by IAMGOLD in 2020 and 2021. One of the priority targets is the eastern extension of the Nelligan mineralized trend where IAMGOLD is planning to complete a minimum of 1,200 meters in November and December. Since IAMGOLD optioned the Project, a detailed till survey, a geophysical Induced Polarization survey and a structural model were completed. Based on these results, several targets were selected where the summer field work focused. This first drilling program targets gold anomalies in the tills coinciding with the geophysical anomalies and the extensions of shear zones from Nelligan deposit, or presenting similar signatures.

07:18 EST Lantronix provides connectivity solution, allows remote management - Lantronix provides an "all-in-one connectivity solution that delivers real-time management and monitoring of distributed retail sites and pop-up stores, improving operational efficiency and increases uptime, helping stores grow revenues," the company said. "Controlling the connectivity at small retail stores and pop-up sites can be daunting. With networks increasingly deploying IT infrastructure in remote locations and data is collected closer to its source, there's a greater need to remotely monitor and manage the equipment from a central location," said Jacques Issa, VP of Marketing at Lantronix. "Lantronix's all-in-one solution provides a secure connection through a secondary interface that is physically separate from the primary network connection, enabling troubleshooting and remediation at the edge to be quickly addressed to avoid a catastrophic network failure," he added. Case Study: Global Remote Environment Management of Retail Stores and Pop-up Sites. Lantronix all-in-one connectivity solution, comprising Lantronix SLB, ConsoleFlow and Lantronix Connectivity Services, delivered a secure solution for global remote environment management of retail stores and pop-up sites, including hardware, software and cellular connectivity. Challenge: Remotely Manage Distributed Sites to Ensure Uptime.

07:13 EST Toyota debuts all-electric bZ4X - Toyota's all-electric bZ4X made its U.S. production model debut on November 17. As a leader in electrification, Toyota's introduction of bZ4X represents the first of a global series of battery-electric vehicles to be introduced under the global "Toyota bZ" brand umbrella. The bZ4X will have a manufacturer-estimated range of up to 250 miles for XLE front-wheel drive models. Toyota plans to expand to around 70 electrified models globally by 2025. This future lineup will feature 15 dedicated BEVs, including seven carrying the bZ (Beyond Zero) brand moniker. This diverse portfolio of electrified products will help propel Toyota toward its goal of carbon neutrality by 2050.

07:12 EST Fairfax Financial announces $1B substantial issuer bid, sale of Odyssey stake - Fairfax Financial Holdings Limited announces its intention to commence a substantial issuer bid pursuant to which the Company will offer to repurchase for cancellation up to $1B of its subordinate voting shares from shareholders for cash. Fairfax also announces that it has entered into an agreement with an affiliate of CPPIB Credit Investments, a wholly-owned subsidiary of Canada Pension Plan Investment Board, and OMERS, the defined benefit pension plan for Ontario's municipal sector employees pursuant to which each of CPPIB Credit Investments and OMERS will acquire 100% of a new series of securities representing a 4.995% interest in Odyssey Group Holdings, Fairfax's U.S. based reinsurance and insurance subsidiary, for an aggregate cash purchase price of $900M. After closing, Fairfax will retain the flexibility to repurchase the interests of OMERS and CPPIB Credit Investments in Odyssey Group over time. The Offer will proceed by way of a "modified Dutch auction", which allows shareholders to select the price, within the specified range, at which each shareholder is willing to sell all or a portion of their Shares. The Offer prices range from $425.00 to $500.00 per Share. The Offer will be for up to a maximum of 2,352,941 Shares, or approximately 8.72% of Fairfax's 26,986,170 total issued and outstanding Shares, based on full participation and a purchase price equal to the minimum purchase price per Share. Shareholders who wish to participate in the Offer will be able to do so through auction tenders in which they will specify the number of Shares being tendered at a price of not less than $425.00 and not more than $500.00 per Share, in increments of $5.00 per Share; or purchase price tenders in which they will not specify a price per Share, but rather, will agree to have a specified number of Shares purchased at the purchase price to be determined by auction tenders. Shareholders who validly deposit Shares without specifying the method in which they are tendering their Shares will be deemed to have made a purchase price tender. Fairfax has been informed by Mr. Watsa that he, and entities controlled by him, will not deposit any Shares owned or controlled by him pursuant to the Offer. Upon expiry of the Offer, Fairfax will determine the lowest purchase price that will allow the Company to purchase the maximum number of Shares properly tendered to the Offer, and not properly withdrawn, having an aggregate purchase price not exceeding $1B.

07:09 EST Optinose lowers FY21 XHANCE net revenue view to $71M-$75M from 'at least' $80M - Optinose also "expects full year 2021 XHANCE net revenue per prescription to be greater than $210. Previously the company expected full year 2021 XHANCE net revenue per prescription to be greater than $200."

07:08 EST ZIM Integrated jumps 10% to $54.93 after Q3 results beat estimates

07:07 EST Eloxx Pharmaceuticals reports results form Phase 2 trial of ELX-02 - Eloxx Pharmaceuticals announced positive topline results from the monotherapy arms of its Phase 2 clinical trial of ELX-02 in Class 1 cystic fibrosis, CF, patients with at least one G542X nonsense allele mutation. ELX-02 was well tolerated and achieved a statistically significant 5.4mmol/L reduction in sweat chloride in patients at the1.5mg/kg/day dose. The intra-patient dose escalation stage of the trial has successfully identified 1.5 mg/kg/day as the dose for further development. Based on the statistically significant monotherapy results observed at the 1.5mg/kg/day dose, planning for the advancement of ELX-02 into Phase 3 clinical development has started. The Phase 2 clinical trial of ELX-02 was designed to evaluate safety and assess biological activity in G542X nonsense mutation Class 1 CF patients as monotherapy and in combination with ivacaftor. Topline results for the intra-patient dose escalation monotherapy arms are summarized below: ELX-02 was generally well tolerated in the trial, with no treatment-related serious adverse events noted; the study met a key secondary endpoint by showing a statistically significant reduction in mean sweat chloride of 5.4 mmol/L after one week of therapy for ELX-02 dosed at 1.5mg/kg/day; while the trial was not designed as a longer-term efficacy study and did not compare ELX-02 to any other agent, results from prior Phase 2 trials with FDA-approved agents for CF can serve as a contextual reference for the level of sweat chloride reduction observed and its potential clinical relevance; and treatment with both these agents resulted in improved lung function as measured by forced expiratory volume FEV1 with longer treatment duration in subsequent Phase 3 trials with Orkambi and Symdeko. Planned Next Steps for ELX-02 CF Program: First patient dosing has occurred in the expansion arm of the Phase 2 trial, which includes a combination of ELX-02 and Kalydeco, a CFTR protein potentiator. In preclinical studies, Class 1 CF patient organoids had a 2- to 3-fold higher swelling response with a combination of ELX-02 and Kalydeco than with ELX-02 as a monotherapy. Topline results are expected by the end of the first half of 2022. Inhaled delivery of ELX-02: Eloxx has also begun evaluation of inhaled delivery of the current subcutaneous formulation of ELX-02. We expect to submit an Investigational New Drug application the second half of 2022.

07:06 EST Virtuoso anounces shareholder approval of proposed SPAC merger with Wejo Group - Virtuoso Acquisitio (VOSO), a publicly traded special purpose acquisition company announced that Virtuoso stockholders voted to approve its proposed merger with Wejo Group Limited at a Special Meeting of Shareholders held on November 16. The merger is expected to close on November 18, and the common stock and warrants of the combined company, which will be called Wejo, are expected to commence trading on the Nasdaq Stock Market on November 19, under the new ticker symbols, "WEJO" and "WEJOW," respectively. "We are very pleased to achieve this important milestone in the merger process and thank our stockholders for their support," said Jeffrey D. Warshaw, Chairman and CEO of Virtuoso. "Wejo has built significant momentum in its business and is demonstrating the huge potential of connected vehicle data through the continued development of its technology platform, as well as its important collaborations with many market-leading companies and OEMs. We are excited to support Wejo as a public company and further establish it as the global leader in connected vehicle data." The formal results of the vote will be included in a Current Report on Form 8-K, to be filed by Virtuoso with the Securities and Exchange Commission.

07:06 EST GXO Logistics, DSA WorkFit partnership welcomes 22nd recruit - GXO Logistics recently welcomed its 22nd Down Syndrome hire. GXO, through its long-term partnership with the Down Syndrome Association's WorkFit programme, is continuing to expand its commitment to diversity, inclusion and belonging and expects to welcome more hires to the programme in 2022.

07:05 EST Honeywell expands Baton Rouge facility for low-global-warming solution - Honeywell announced the expansion of its facility in Baton Rouge, La. to double the capacity of its Solstice ze, an ultra-low-global-warming-potential - GWP - solution. Solstice ze is used in foam insulation, as a propellant in personal and household care products, and in refrigeration and air conditioning applications. Honeywell will invest capital in the facility for the growth of Solstice ze, which is part of the company's Solstice line of products based on hydrofluoroolefin technology that helps customers lower their carbon footprint. Multiple global regulations require the phasedown of hydrofluorocarbons, driving the demand for sustainable solutions.

06:59 EST Biohaven Pharmaceutical receives Kuwait Ministry of Health approval for Nurtec - Biohaven Pharmaceutical announced that Nurtec ODT was approved by the Kuwait Ministry of Health for the acute treatment of migraine with and without aura in adults. Nurtec ODT is the first and only calcitonin gene-related peptide receptor antagonist available in a fast-acting orally disintegrating tablet approved for the acute treatment of migraine.

06:56 EST Gates Industrial announces $200M share repurchase program - Gates Industrial announced that its board of directors has authorized a share repurchase program of up to $200M of the company's ordinary shares. This authorization is valid through December 31.

06:52 EST Meritor selected to provide ePowertrain for Electra Commercial Vehicles - Meritor announced it was selected by Electra Commercial Vehicles to provide its Blue Horizon 14Xe integrated ePowertrain for testing on their Iveco-based electric road sweeper platform. The 14Xe ePowertrain, will be delivered to Electra by the end of the year, and will be integrated on a road sweeper for testing in Wales.

06:47 EST Barnes Group launches corporate rebrand - Barnes announced a corporate rebrand and launch. Barnes is focused on being a global technology-driven company. The new branding will be rolled out across the globe in the coming weeks and includes a newly launched website.

06:44 EST GSK, Vir report U.S. government agreements to purchase sotrovimab for COVID-19 - GlaxoSmithKline (GSK) and Vir Biotechnology (VIR) announced U.S. government contracts totaling approximately $1B to purchase sotrovimab, an investigational monoclonal antibody for the early treatment of COVID-19, which the US Food and Drug Administration granted Emergency Use Authorization in May 2021. GSK will supply these doses to the US government by December 17, 2021, enabling further expanded nationwide access to sotrovimab for patients. In addition to the doses that will be supplied this year, the U.S. government will have the option to purchase additional doses through March 2022. Including the contracts announced today, GSK and Vir have received binding agreements for the sale of more than 750,000 doses of sotrovimab worldwide, with additional doses reserved through other agreements including the previously announced Joint Procurement Agreement with the European Commission. Dr Hal Barron, Chief Scientific Officer and President R&D, GSK, said: "Given the large number of patients who continue to become ill with COVID-19 across many regions in the US, there is an ongoing need for access to effective treatments. We are proud to work with the US government to help make sotrovimab available for these patients." George Scangos, Ph.D., Chief Executive Officer of Vir, said: "Monoclonal antibodies play an essential role in the treatment of certain patients with COVID-19, and we're grateful that this agreement will allow more healthcare providers and patients who are at high risk for progression to severe COVID-19 to access sotrovimab. Given ongoing evidence, which demonstrates its ability to maintain activity against the tested circulating variants of concern, including Delta, we are confident sotrovimab will continue to be important in the fight against COVID-19."

06:42 EST GSK announces European Commission approves Nucala in added diseases - GlaxoSmithKline announced that the European Commission has approved Nucala, a monoclonal antibody that targets interleukin-5, or IL-5, for use in three additional eosinophil-driven diseases. This authorization follows positive opinions recommended by the Committee for Medicinal Products for Human Use and authorizes mepolizumab for use as an add on treatment in hypereosinophilic syndrome, or HES, eosinophilic granulomatosis with polyangiitis, or EGPA, and chronic rhinosinusitis with nasal polyps, or CRSwNP. Dr. Hal Barron, Chief Scientific Officer and President R&D, GSK, said: "With millions of patients across Europe affected by eosinophil-driven diseases, we recognize the urgency in delivering the first approved targeted treatment for use in four of these conditions. Today's approvals reinforce the important role treatments such as mepolizumab can play in helping to improve the lives of patients with these debilitating diseases."

06:35 EST CGI Inc. awarded 10-year ASTRO IDIQ contract from GSA - CGI has been selected by the General Services Administration, or GSA, for the multi-award ASTRO Indefinite-Delivery/Indefinite-Quantity, or IDIQ, contract. This 10-year award provides CGI the opportunity to compete for task orders with an unlimited ceiling value to research, develop, support, maintain and operate manned, unmanned and optionally manne platforms and robotics, such as satellites, launch vehicles and related services.

06:33 EST Target sees Q4 comparable sales up high-single digits to low-double digits - The company said, "For the fourth quarter 2021, the Company expects high-single digit to low-double digit growth in comparable sales, compared with the previous guidance for a high-single digit increase. The Company continues to expect its full-year operating income margin rate will be 8 percent or higher."

06:14 EST Energous' 1-Watt WattUp PowerBridge transmitter approved in Europe - Energous' 1W WattUp PowerBridge has completed regulatory review with an internationally accredited European Notified Body. The results of this review verify that the Energous 1W WattUp PowerBridge transmitter complies with European technical requirements for radio equipment. The approval in Europe follows the recent FCC approval for the 1W WattUp PowerBridge. Energous has recently received two major regulatory approvals - including FCC approval of its 1W WattUp PowerBridge transmitter for wireless power transfer at any distance as well as European regulatory approval for WattUp PowerHub for its wireless charging technology. WattUp is suitable for a range of applications from small form factor devices to industrial IoT sensors to larger electronics and peripherals.

06:11 EST Ensign Group acquires real estate in Arizona, California and Kansas - The Ensign Group announced that it acquired the real estate at the following skilled nursing and assisted living facilities in Arizona, California and Kansas, which acquisitions were effective November 15, 2021: Horizon Post-Acute and Rehabilitation Center, a 179-bed skilled nursing facility located in Glendale, AZ, which is operated by an independent operating subsidiary of Ensign; Mission Care Center, a 58-bed skilled nursing facility located in Rosemead, CA, which is operated by an independent operating subsidiary of Ensign; California Mission Inn, a 144-bed assisted living facility located in Rosemead, CA, which is operated by an independent operating subsidiary of The Pennant Group, Inc.; The Healthcare Resort of Leawood, a 94-bed skilled nursing facility located in Leawood, KS, which is operated by an independent operating subsidiary of Ensign; and The Healthcare Resort of Topeka, a 105-bed skilled nursing facility located in Topeka, KS, which is operated by an independent operating subsidiary of Ensign.

06:04 EST Curo Group to acquire Heights Finance for $360M - Curo Group announced that it has entered into a definitive agreement to acquire Heights Finance, a consumer finance company that provides installment loans and offers customary opt-in insurance and other financial products, from Milestone Partners, a private equity firm based in Radnor, Pennsylvania. Total consideration of $360M is comprised of $335M cash and $25M of CURO common stock. Heights Finance primarily serves near-prime and non-prime customers through a network of 390 branches across 11 southern and mid-western states. The acquisition is expected to accelerate CURO's transition into longer-term, higher balance and lower rate credit products. For the 12 months ended September 30, 2021, Heights Finance had revenue of $235M and adjusted pre-tax income of $34M. The acquisition's aggregate purchase price of $360M represents 6.5x Heights Finance's 2022 estimated adjusted earnings before taxes of $55M. The acquisition is immediately accretive to CURO's earnings. The transaction has been approved by CURO's Board of Directors and is expected to close no later than the first quarter of 2022, subject to customary closing conditions, including licensing approvals. CURO expects to fund the acquisition through a combination of existing cash and debt.

05:30 EST Rogers Communications CEO Joe Natale leaves, Tony Staffieri named interim CEO - Rogers Communications announced that Joe Natale has left his role as president and CEO of the company effective immediately. Tony Staffieri has been appointed interim president and CEO. Staffieri has over thirty years of telecom, financial, media and sports experience, including over nine years as the CFO of Rogers. The board has begun a search to identify a permanent CEO who will continue to drive future growth including integration with the Shaw team once the deal closes next year. Tony Staffieri will be a candidate for this role. The Shaw transaction continues to move forward as planned. On Monday, November 22, the Rogers and Shaw teams, including Edward Rogers, will attend the CRTC public hearing.

05:21 EST AbbVie receives EC approval for Skyrizi - AbbVie announced that the European Commission, or EC, has approved Skyrizi alone or in combination with methotrexate, for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying anti-rheumatic drugs, or DMARDs. Marking the second indication for Skyrizi, the marketing authorization will be valid in all member states of the European Union, as well as Iceland, Liechtenstein, Norway and Northern Ireland.

05:15 EST Bragg Gaming announces Oryx Gaming launches platform in Dutch market - Oryx Gaming, a Bragg Gaming company, launched its platform in the newly regulated Dutch market after going live - on the first day of regulated online casino trading in October - with the BetCity.nl brand under a full turnkey agreement with local operator BetEnt. BetEnt, the online arm of Dutch land-based operator Casino City, selected Oryx to provide it with a complete solution including its Player Account Management iGaming Platform and content library.